Arkolith/Insider Trading/FHTX/Form 4

Agresta Samuel

Chief Medical OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Aug 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.6M
Net Open-Market Flow
-$2.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2023Option exercise(M)311K$3.72$1.2M311K
Aug 16, 2023Sell(S)311K$8.25$2.6M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 16, 2023Option exercise(M)311K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-006433) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML